Central Nervous System Treatment Market Size, Share, Trends & Industry Analysis, By Disease Type (Neurovascular Diseases, Neurodegenerative Diseases, Mental Health, Infectious Diseases, and Others), By Drug Class (Immunomodulatory Drugs, Interferons, Decarboxylase Inhibitors, Dopamine Agonists, Antidepressants, Others) By Drug Type (Biologics and Non-biologics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), and Regional Forecast, 2021-2028

  ATTRIBUTE

  DETAILS

Study Period

2017-2028

Base Year

2020

Estimated Year

 2021

Forecast Period

2021-2028

Historical Period

2017-2019

Unit

Value (USD billion)

Segmentation

Disease Type, Drug Class, Drug Type, Distribution Channel, and Region

By Disease Type

• Neurovascular Diseases
  • Hemorrhagic Stroke
  • Ischemic Stroke
  • Others
• Neurodegenerative Diseases
  • Alzheimer’s Disease
  • Parkinson’s Disease
  • Multiple Sclerosis
  • Others
• Mental Health
  • Epilepsy
  • Mood Disorders
  • Anxiety Disorders
  • Others
• Infectious Diseases
  • Meningitis
  • Encephalitis
  • Others
• Others

By Drug Class

• Immunomodulatory Drugs
• Interferons
• Decarboxylase Inhibitors
• Dopamine Agonists
• Antidepressants
• Analgesics
• Others

By Drug Type

• Biologics
• Non-biologics

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Region

• North America (By Disease Type, By Drug Class, By Drug Type By Distribution Channel, and By Country)
  • U.S. (By Drug Type)
  • Canada (By Drug Type)
• Europe (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and By Country)
  • U.K. (By Drug Type)
  • Germany (By Drug Type)
  • France (By Drug Type)
  • Italy (By Drug Type)
  • Spain (By Drug Type)
  • Rest of Europe (By Drug Type)

• Asia Pacific (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and By Country)

• • China (By Drug Type)
  • Japan (By Drug Type)
  • India (By Drug Type)
  • Australia (By Drug Type)
  • Southeast Asia (By Drug Type)
  • Rest of Asia Pacific (By Drug Type)
• Latin America (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and by Country)
  • Brazil (By Drug Type)
  • Mexico (By Drug Type)
  • Rest of Latin America (By Drug Type)
• Middle East & Africa (By Disease Type, By Drug Class, By Drug Type, By Distribution Channel, and by Country)
  • GCC (By Drug Type)
  • South Africa (By Drug Type)
  • Rest of Middle East & Africa (By Drug Type)